Article
What Do German Molecular Tumor Boards Recommend in Patients with PIK3CA-Mutated Tumors? Launch and First Results from the German Transsectoral Molecular Tumor Board Exchange Platform Deutschland.
Oncology research and treatment - 1 Jan 2024
Pretzell Ina, Desuki Alexander, Bleckmann Annalen, Loges Sonja, Reinacher-Schick Anke, Westphalen C Benedikt, Lange Sebastian
Abstract excerpt
INTRODUCTION: Comprehensive molecular tumor profiling is widely used in the management of patients with cancer. Molecular tumor boards devise treatment strategies based on testing results. In this setting, the Transsectoral Molecular Tumor Board exchange platform Deutschland (TEAM-D) aims to drive peer-to-peer exchange to connect experts in the field. METHODS: During the first virtual TEAM-D meeting, participants...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.